Diagnosing and understanding psoriatic arthritis
ARTICLE SUMMARY: Psoriatic arthritis is a form of arthritis often seen in psoriasis patients. It causes pain, swelling, and stiffness of one or more joints. Left untreated, it can cause permanent damage. So seeking diagnosis and treatment of psoriatic arthritis is very important.
FDA wants more research before considering Pfizer RA drug Xeljanz for use in psoriasis
On October 14, 2015, Pfizer announced that the US Food and Drug Administration (FDA) has declined to approve Pfizer’s rheumatoid arthritis drug Xeljanz (tofacitinib citrate) to treat moderate to severe plaque psoriasis in adult patients.
The FDA, in what is called a Complete Response Letter, made recommendations to Pfizer about what additional information it should provide to try again to win approval of Xeljanz for psoriasis.
If you have psoriasis or psoriatic arthritis, investigate new treatments that are transforming lives
Treatment options for psoriasis and psoriatic arthritis have exploded over the last 20 years, and new treatments continue to come to market.
We are finally approaching a situation where the best of old treatments and cutting-edge new treatments are giving physicians the ability to target more appropriate strategies for each patient.
In other words, if you are not currently treating your psoriasis or are not happy with your current regimen, get to a dermatologist and learn about all your options.
While there is still no cure for psoriasis or psoriatic arthritis, most patients can now find a treatment that works for them. Go for it.